Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Sandra Peterson To Join Johnson & Johnson On Dec. 1 As Group Worldwide Chairman

RELATED NEWS
Trade JNJ now with 

Johnson & Johnson (JNJ: Quote) announced Sandra Peterson will join it on December 1, as Group Worldwide Chairman and member of Executive Committee. Peterson will have responsibility for the Consumer Group of Companies, Information Technology, and Global Supply Chain. She will be based at Johnson & Johnson headquarters in New Brunswick, New Jersey.

Sandra Peterson is currently the Chairman and Chief Executive Officer of Bayer CropScience AG, based in Europe. Peterson has held her current role at Bayer since 2010. Previously, she was president and chief executive officer of Bayer Medical Care and president of Bayer HealthCare AG's Diabetes Care Division.

Click here to receive FREE breaking news email alerts for Johnson & Johnson and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.